CTOs on the Move

Dracen Pharmaceuticals

www.dracenpharma.com

 
Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.dracenpharma.com
  • 1812 Ashland and Avenue 1st Floor, Suite 100
    Baltimore, MD USA 21205
  • Phone: 917.398.3710

Executives

Name Title Contact Details

Funding

Dracen Pharmaceuticals raised $40M on 03/22/2018

Similar Companies

Apotex

Apotex is the largest Canadian owned pharmaceutical company, and the largest producer of generic medicines in the country. Founded in 1974, Apotex has steadily grown to employ over 10,000 people around the world, focused on research, development, manufacturing and distribution.

Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Iris Telehealth

Iris Telehealth beats the other telepsychiatry companies. Partner with Iris to build a telepsychiatry program that improves patient outcomes.

Vernalis

Vernalis plc is a revenue generating development stage pharmaceutical company with one marketed product, frovatriptan, and a broad pipeline of research and development programmes. The business model is a balance between risk and innovation with the aim of creating value through a focused and disciplined strategy. An exclusive development and licensing agreement with Tris Pharma to develop multiple novel products focussed on the US prescription cough cold market is the platform for Vernalis to build a profitable and cash generative commercial business in the US. These novel products are low risk, late stage and differentiated for an unmet need. Value is also being extracted from the legacy NCE pipeline where the model is to selectively invest and then partner these programmes, earning milestones and royalties as partners progress them at their expense. Vernalis also exploits its significant expertise in fragment and structure based drug discovery by entering into collaborations with larger pharmaceutical companies. Its technologies and capabilities have been endorsed, over the last five years, through collaborations with leading pharmaceutical companies, including Biogen Idec, Endo, GSK, Genentech, Lundbeck, Menarini, Novartis, Servier and Tris Pharma.